AngioDynamics (ANGO)
(Real Time Quote from BATS)
$5.86 USD
+0.10 (1.74%)
Updated Jun 27, 2024 03:08 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Brokerage Reports
AngioDynamics, Inc. [ANGO]
Reports for Purchase
Showing records 61 - 80 ( 411 total )
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Modest Miss on Choppy 1Q, Reaffirmed FY23 Guidance
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Jury Verdict Likely Not Impactful to the Stock; Just Some Lost Legal Fees
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Company: AngioDynamics, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department